OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medicinal polypharmacology: Exploration and exploitation of the polypharmacolome in modern drug development
Sven Marcel Stefan, Muhammad Rafehi
Drug Development Research (2023) Vol. 85, Iss. 1
Open Access | Times Cited: 15

Showing 15 citing articles:

Medicinal Polypharmacology in the Clinic – Translating the Polypharmacolome into Therapeutic Benefit
Muhammad Rafehi, Marius Möller, Wouroud Ismail Al-khalil, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 3, pp. 411-417
Open Access | Times Cited: 11

Computer-aided pattern scoring – A multitarget dataset-driven workflow to predict ligands of orphan targets
Katja Stefan, Vigneshwaran Namasivayam, Sven Marcel Stefan
Scientific Data (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 8

Functional and Structural Polypharmacology of Indazole-based Privileged Ligands to Tackle the Undruggability of Membrane Transporters
Sven Marcel Stefan, Sachin Puri, Muhammad Rafehi, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117234-117234
Open Access | Times Cited: 1

Toward structure–multiple activity relationships (SMARts) using computational approaches: A polypharmacological perspective
Edgar López‐López, José L. Medina‐Franco
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104046-104046
Closed Access | Times Cited: 6

Medicinal polypharmacology—a scientific glossary of terminology and concepts
Sven Marcel Stefan, Muhammad Rafehi
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5

Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)
Jörg Haupenthal, Muhammad Rafehi, Andreas M. Kany, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 9
Open Access | Times Cited: 4

HD_BPMDS: a curated binary pattern multitarget dataset of Huntington’s disease–targeting agents
Sven Marcel Stefan, Jens Pahnke, Vigneshwaran Namasivayam
Journal of Cheminformatics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 10

Computer-aided pattern scoring (C@PS): a novel cheminformatic workflow to predict ligands with rare modes-of-action
Sven Marcel Stefan, Sven Marcel Stefan, Vigneshwaran Namasivayam
Journal of Cheminformatics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2

Mobocertinib antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells: in vitro and in vivo studies
Xing-Duo Dong, Meng Zhang, Qiu‐Xu Teng, et al.
Cancer Letters (2024), pp. 217309-217309
Closed Access | Times Cited: 2

We are MedChem: The Frontiers in Medicinal Chemistry 2024
Matthias Schiedel, Philipp Barbie, Felix Pape, et al.
ChemMedChem (2024)
Closed Access

Predictive, Integrative, and Regulatory Aspects of AI-Driven Computational Toxicology – Highlights of the German Pharm-Tox Summit (GPTS) 2024
Ute Haßmann, Steffen Amann, Nelly Babayan, et al.
Toxicology (2024) Vol. 509, pp. 153975-153975
Closed Access

Page 1

Scroll to top